https://www.selleckchem.com/pr....oducts/itacnosertib.
513; p= 0.009) on hospital admission and with number of haemodialysis sessions (r= 0.406; p= 0.049). No significant correlation was found with FGF-23. Regarding prognostic performance, combined syndecan-1 and angiopoietin-2 levels had a better ability to predict haemodialysis need in patients with severe leptospirosis (AUC-ROC=0.744 [95% CI 0.545-0.943] p= 0.035). Syndecan-1 and angiopoietin-2 were associated with haemodialysis need in patients with severe leptospirosis and may be useful to improve therapeutic approach and reduce m
Beğen
Yorum Yap
Paylaş
